Transcranial brain parenchyma sonography in movement disorders: State of the art

被引:205
作者
Walter, Uwe
Behnke, Stefanie
Eyding, Jens
Niehaus, Ludwig
Postert, Thomas
Seidel, Guenter
Berg, Daniela
机构
[1] Univ Rostock, Dept Neurol, D-18147 Rostock, Germany
[2] Univ Saarland, Dept Neurol, D-6650 Homburg, Germany
[3] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-4630 Bochum, Germany
[4] Otto Von Guericke Univ, Dept Neurol 2, Magdeburg, Germany
[5] St Vincenz Hosp Paderborn, Dept Neurol, Paderborn, Germany
[6] Med Univ Lubeck, Hosp Schleswig Holstein, Dept Neurol, Lubeck, Germany
[7] Univ Tubingen, Inst Med Genet, Tubingen, Germany
[8] Univ Tubingen, Hertie Inst Brain Res, Tubingen, Germany
关键词
transcranial sonography; brain parenchyma sonography; neurodegenerative disease; movement disorder; substantia nigra; lenticular nucleus; caudate nucleus; cerebellum; ventricle width; consensus;
D O I
10.1016/j.ultrasmedbio.2006.07.021
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
The present paper summarizes recommendations on transcranial sonography (TCS) application in neurodegenerative diseases, resulting from a consensus meeting of the European Society of Neurosonology and Cerebral Hemodynamics. TCS of distinct infra- and supratentorial brain structures detects characteristic changes in several movement disorders, such as abnormal hyperechogenicity of substantia nigra (SN) in Parkinson's disease and of lenticular nucleus in dystonia, Wilson's disease and atypical Parkinsonian disorders. In healthy adults, the TCS finding of marked SN hyperechogenicity indicates a subclinical functional impairment of the nigrostriatal dopaminergic system. The finding of marked SN hyperechogenicity in combination with normal lenticular-nucleus echogenicity discriminates idiopathic Parkinson's disease from multiple-system atrophy and progressive supranuclear palsy with a positive predictive value of more than 90%. As TCS is a quick and noninvasive method, using the same duplex-ultrasound machines as for investigation of intracranial vessels, applicable even in agitated patients, this method has a great potential to be more widely used. (E-mail: uwe.walter@med.uni-rostock.de) (c) 2006 World Federation for Ultrasound in Medicine & Biology.
引用
收藏
页码:15 / 25
页数:11
相关论文
共 51 条
[31]  
Furuhata H, 1989, NEUROSONOLOGY, V1, P8
[32]   Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles [J].
Hilditch-Maguire, P ;
Trettel, F ;
Passani, LA ;
Auerbach, A ;
Persichetti, F ;
MacDonald, ME .
HUMAN MOLECULAR GENETICS, 2000, 9 (19) :2789-2797
[33]   Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease [J].
Hochstrasser, H ;
Bauer, P ;
Walter, U ;
Behnke, S ;
Spiegel, J ;
Csoti, I ;
Zeiler, B ;
Bornemann, A ;
Pahnke, J ;
Becker, G ;
Riess, O ;
Berg, D .
NEUROLOGY, 2004, 63 (10) :1912-1917
[34]   Postnatal decrease in substantia nigra echogenicity - Implications for the pathogenesis of Parkinson's disease [J].
Iova, A ;
Garmashov, A ;
Androuchtchenko, N ;
Kehrer, M ;
Berg, D ;
Becker, G ;
Garmashov, Y .
JOURNAL OF NEUROLOGY, 2004, 251 (12) :1451-1454
[35]   Differences in substantia nigra echogenicity of nosological subtypes within the schizophrenic spectrum - A preliminary transcranial ultrasound study [J].
Jabs, BE ;
Berg, D ;
Merschdorf, U ;
Bartsch, AJ ;
Pfuhlmann, B .
NEUROPSYCHOBIOLOGY, 2001, 44 (04) :183-186
[36]   2-DIMENSIONAL ECHOENCEPHALOGRAPHY WITH ELECTRONIC SECTOR SCANNING - CLINICAL EXPERIENCES WITH A NEW METHOD [J].
KAMPHUISEN, HA ;
SOMER, JC ;
OOSTERBAAN, WA .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1972, 35 (06) :912-918
[37]   Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra [J].
Kivi, A ;
Trottenberg, T ;
Kupsch, A ;
Plotkin, M ;
Felix, R ;
Niehaus, L .
MOVEMENT DISORDERS, 2005, 20 (02) :258-260
[38]  
Kruse N, 2001, ANN NEUROL, V49, P405
[39]   Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography [J].
Naumann, M ;
Becker, G ;
Toyka, KV ;
Supprian, T ;
Reiners, K .
NEUROLOGY, 1996, 47 (05) :1284-1290
[40]  
NIEHAUS L, 2004, CEREBROVASC DIS, V17, P3